Rubicon Research Limited (BOM:544578)
India · Delayed Price · Currency is INR 1,597.30
-12.35 (-0.77%)
At close: Oct 6, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 264.32 billion as of October 7, 2026.
Market Cap
264.32B
Enterprise Value
264.10B
Revenue
19.36B
Global Rank
n/a
Country Rank
n/a
PE Ratio
91.71
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 264.32B, an increase of 155.39%. That is a compound annual growth rate of 161.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 260.81B | 132.55% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lupin | 927.73B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |
| Jubilant Pharmova | 158.49B |
| AstraZeneca Pharma India | 150.76B |